IPCA Laboratories informs about analyst meet outcome

19 Aug 2024 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, IPCA Laboratories has enclosed transcript of Conference Call which was held on Wednesday, 14th August, 2024 to discuss the Company’s Q1FY25 earnings and business update.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories Share Price

1589.45 16.25 (1.03%)
22-Nov-2024 13:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.75
Dr. Reddys Lab 1213.40
Cipla 1489.10
Lupin 2062.60
Zydus Lifesciences 948.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.